TY - JOUR
T1 - Methods in tubulin proteomics
AU - Miller, Leah M.
AU - Xiao, Hui
AU - Burd, Berta
AU - Horwitz, Susan Band
AU - Angeletti, Ruth Hogue
AU - Verdier-Pinard, Pascal
N1 - Funding Information:
This work has been supported by NIH grants CA077263 and CA124898, the National Foundation for Cancer Research (S.B.H.), NIH grant R33CA101150 (R.H.A.), and NIH grant CA125923 (L.M.M).
PY - 2010
Y1 - 2010
N2 - New analytical methods are needed for the successful outcome of experiments aimed at characterizing mechanisms of microtubule dynamics and at understanding the effects of drugs on microtubules. The identification of tubulin isotypes and of regions of the microtubule involved in drug interactions has been advanced by proteomic methodologies. The diversity of tubulin sequences and posttranslational modifications (PTMs) can generate a complex mixture of heterodimers with unique molecular dynamics driving specific functions. Mass spectrometry (MS)-based approaches have been developed, and in combination with chromatographic and/or electrophoretic separation of tubulin polypeptides or peptides, they have contributed to our understanding of tubulin proteomics. We present protocols that we have used for the analysis of tubulin isotypes and PTMs present in tubulin isolated from cells in culture or tissues and for the identification of tubulin regions altered by microtubule-stabilizing agents. Tubulin proteomics complements structural and computer modeling information for a high-resolution view of microtubule dynamics and its alteration by drugs. These methodologies will help in providing insights into tubulin isotype-specific functions and in the design of drugs targeting either all tubulin heterodimers indiscriminately or only those containing specific isotypes.
AB - New analytical methods are needed for the successful outcome of experiments aimed at characterizing mechanisms of microtubule dynamics and at understanding the effects of drugs on microtubules. The identification of tubulin isotypes and of regions of the microtubule involved in drug interactions has been advanced by proteomic methodologies. The diversity of tubulin sequences and posttranslational modifications (PTMs) can generate a complex mixture of heterodimers with unique molecular dynamics driving specific functions. Mass spectrometry (MS)-based approaches have been developed, and in combination with chromatographic and/or electrophoretic separation of tubulin polypeptides or peptides, they have contributed to our understanding of tubulin proteomics. We present protocols that we have used for the analysis of tubulin isotypes and PTMs present in tubulin isolated from cells in culture or tissues and for the identification of tubulin regions altered by microtubule-stabilizing agents. Tubulin proteomics complements structural and computer modeling information for a high-resolution view of microtubule dynamics and its alteration by drugs. These methodologies will help in providing insights into tubulin isotype-specific functions and in the design of drugs targeting either all tubulin heterodimers indiscriminately or only those containing specific isotypes.
UR - http://www.scopus.com/inward/record.url?scp=77955296287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955296287&partnerID=8YFLogxK
U2 - 10.1016/S0091-679X(10)95007-3
DO - 10.1016/S0091-679X(10)95007-3
M3 - Article
C2 - 20466132
AN - SCOPUS:77955296287
SN - 0091-679X
VL - 95
SP - 105
EP - 126
JO - Methods in Cell Biology
JF - Methods in Cell Biology
IS - C
ER -